Signals, Powered By EquityPandit
Glenmark Pharmaceuticals, receives final approval from the US health regulator for Desonide lotion which is used for skin rashes and irritation.
In a regulatory filing the company said,”Glenmark Pharmaceuticals has been granted final approval by the United States Food and Drug Administration(USFDA) for Desonide lotion,0.05 per cent.”
Further, the company currently has a portfolio of 126 products authorized for distribution in the US market and 61 abbreviated new drug applications(ANDAs) pending for approval with USFDA.
